4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-14-074740
Options or other derivatives
- VP of Clinical Development acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Szakacs Cameron VP of Clinical Development | 2014-11-24 | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/v396957_4.xml…